New Horizon Aircraft Ltd Dossier
|
SectorIndustrials IndustryAerospace & Defense Beta (adjusted)2.91 Intrinsic Value Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet. Market Price $1.67Price as of 1 Oct 2026 Data confidenceNot applicable Market Cap $112.1M Enterprise Value $92.4M Shares Outstanding 67.1M diluted Next Earnings Date15 Oct 2026 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary New Horizon Aircraft Ltd. (NASDAQ: HOVR) is a structurally mispriced player in the advanced air mobility (AAM) sector. Unlike pure-electric eVTOL competitors that face severe battery-density and charging-infrastructure constraints, Horizon's Cavorite X7 utilizes a hybrid-electric system (combining a Pratt & Whitney PT6 class turbine engine with electric subsystems). This design delivers up to 30% lower hydrocarbon emissions than conventional aircraft, provides all-weather capability, and offers up to 75% lower operating costs than legacy helicopters. With the recent closing of a $25 million registered direct offering, the company is fully funded to complete its full-scale prototype by the end of 2026 and transition to flight testing in early 2027. Trading at a fraction of the valuation of its pure-play peers, HOVR offers asymmetric upside as it achieves key engineering and certification milestones. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Street view · analyst 12-month targets Low · most bearish analyst$3.23 Mean target$8.32 High · most bullish analyst$18.00 Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario $3.2515% Technical bottlenecks or supply chain disruptions delay the completion of the full-scale prototype beyond 2026. Flight testing is pushed back, forcing the company to raise additional capital under unfavorable terms, causing severe shareholder dilution. Regulatory hurdles with Transport Canada or the FAA extend the certification timeline beyond 2030. Base CaseCentral scenario $3.2560% The company completes the Cavorite X7 prototype by the end of 2026 and initiates flight testing in early 2027. Cash on hand (strengthened by the May 2026 capital raise) provides a runway through fiscal 2027, minimizing near-term dilution. Certification progresses steadily in partnership with Cert Center Canada (3C), keeping the company on track for commercialization by 2028-2030. Bull CaseUpside scenario $18.0025% The Cavorite X7 prototype successfully completes assembly in late 2026 and begins flight testing in early 2027 without delays. The company secures non-dilutive military development contracts from Canadian or U.S. defense departments, leveraging its dual-use strategy. Commercial pre-orders accelerate, and the company establishes its operating cost advantage of $0.97 per seat mile, leading to rapid market revaluation toward peer multiples. Scenarios are anchored to street consensus at the research date, with our probabilities and rationale. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |